© Newsfile
09.01.2026
HBFG
LISTED
CSE
Happy Belly Food Group's Rosie's Burgers Announces the Grand Opening of Its Newest Location in Calgary's Marda Loop Neighbourhood
News Preview
Toronto, Ontario--(Newsfile Corp. - January 9, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands, is pleased to announce the grand opening of its newest Rosie's Burgers ("Rosie's") restaurant this Saturday, January 10th, located in the highly sought-...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
VEEV
LISTED
NYSE
Veeva und BioMarin schließen langfristige strategische Partnerschaft
News Preview
Partnerschaft zur Unterstützung von BioMarin bei der Beschleunigung und Effizienzsteigerung der Entwicklung und Vermarktung innovativer TherapienPLEASANTON, Kalifornien, und SAN RAFAEL, Kalifornien, 9. Januar 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) und BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) gaben eine langfristige Unternehmensvereinba...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
QURE
LISTED
NASDAQ
uniQure Announces Type A Meeting Scheduled with FDA
News Preview
LEXINGTON, Mass. and AMSTERDAM, Jan. 09, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced a Type A meeting with the U.S. Food and Drug Administration (FDA) has been scheduled to discuss the Biologics License Application (...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
09.01.2026
OCGN
LISTED
NASDAQ
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference
News Preview
MALVERN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen, will present at the 44th Annual J.P. Morgan Healthcare Conference taking place January...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
09.01.2026
KZR
LISTED
NASDAQ
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
News Preview
Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that the Food and Drug Administration (FDA) Division of Hepatology and Nutrition has granted Kezar a Type C meeting for the first quarter to discuss the develo...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ATHA
LISTED
NASDAQ
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”
News Preview
Athira Pharma, Inc. today announced that it has changed its name to LeonaBio, Inc....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISR
LISTED
XASE
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium
News Preview
SEATTLE, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company that is pioneering advanced treatments for cancers throughout the body, announced updated interim results from its ongoing Phase 1/2a clinical trial of [21...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
IMCR
LISTED
NASDAQ
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
News Preview
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
AQST
LISTED
NASDAQ
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
News Preview
WARREN, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today provided an update on the regulatory approval of Anaphylm™ and its b...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
IBIO
LISTED
NASDAQ
iBio Announces $26 Million Private Placement
News Preview
SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that it has entered into a securities purchase agreement with existing healthcare-focused, high-quality institutional investors for a private placement ("PIPE") financing that is expected to result in gros...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
MPLT
LISTED
NASDAQ
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
News Preview
SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase 2 ZEPHYR and IRIS clinical studies, which are progressing ahead of schedule....
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
PODD
LISTED
NASDAQ
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the fourth quarter and full year of 2025 on February 18, 2026, before the opening of the financial markets. In connection with the release, mana...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
09.01.2026
LQDA
LISTED
NASDAQ
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
News Preview
MORRISVILLE, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced preliminary, unaudited full-year 2025 net product sales of YUTREPIA™ (treprostinil) inhalatio...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
RDNT
LISTED
NASDAQ
RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026
News Preview
LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice Pr...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
KDEV
LISTED
STO
Karolinska Development AB (publ) announces publication of information document in connection with upcoming rights issue
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
SNWV
LISTED
NASDAQ
Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
News Preview
Sanuwave Health Reports Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue...
Themefolio
Profiler
Peergroup
© EQS Newswire
09.01.2026
FME
LISTED
XETR
Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
News Preview
Bad Homburg, 9. Januar 2026 – Die Fresenius Medical Care AG („Gesellschaft“) hat entschieden, den Rückerwerb der zweiten Tranche des mit einer Ad-hoc-Mitteilung vom 17. Juni 2025 bekanntgegebenen Aktienrückkaufprogramms zu starten. Das Aktienrückkaufprogramm hat ein Volumen von insgesamt EUR 1 Milliarde (ohne Erwerbsnebenkosten).
Die erste Tranche......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
09.01.2026
APVO
LISTED
NASDAQ
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
News Preview
Together with cash on hand, the fully leveraged facility extends Aptevo's funding runway into 2029, enabling achievement of key clinical and preclinical milestones SEATTLE, WA / ACCESS Newswire / January 9, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology Company focused on developing novel immune-oncology therapeutics...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
CLBIO
LISTED
STO
CorlineCorline Biomedical stärker samarbetet med Kardium – genomför riktad emission och upptar lån från Kardium för att mångfaldiga produktionskapaciteten
News Preview
EJ FÖR PUBLICERING, DISTRIBUTION, ELLER OFFENTLIGGÖRANDE, DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA, SYDKOREA ELLER NÅGON ANNAN STAT ELLER JURISDIKTION I VILKEN SÅDAN ÅTGÄRD SKULLE VARA OLAGLIG ELLER INNEBÄRA KRAV PÅ ANDRA ÅTGÄRDER....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
TNG
LISTED
EURONEXT
Transgene Publishes Phase I Data Supporting TG4050’s Potential in Preventing Head and Neck Cancer Relapse
News Preview
Transgene Publishes Phase I Data Supporting TG4050’s Potential
in Preventing Head and Neck Cancer Relapse...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ZEAL
LISTED
CPH
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
News Preview
Press release – No. 2 / 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
TECN
LISTED
SIX
Tecan reports return to sales growth and strong order entry in the second half of 2025
News Preview
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
VEEV
LISTED
NYSE
Veeva stellt eine Umweltüberwachungslösung zur Modernisierung der Qualitätskontrolle in der Fertigung vor
News Preview
Die erweiterten QC-Lösungen von Veeva für die Fertigung automatisieren die Sammlung und Analyse von UmweltprobenBARCELONA, Spanien, 9. Januar 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) kündigte heute eine neue Lösung zur Umweltüberwachung (EM) an, um die Qualitätskontrolle (QC) in der Produktion zu verbessern. Veeva Environmental Monitoring i...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
GLUE
LISTED
NASDAQ
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
News Preview
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
JNJ
LISTED
NYSE
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
News Preview
Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare’s leading, most comprehensive innovation powerhouse, today announced a voluntary agreement with the Trump Administration to improve access to medicines and lower costs for millions of American patients. The joint agreement meets the requests laid out by President Trump to the industry a...
Themefolio
Profiler
Peergroup
© Newsfile
09.01.2026
CHS
LISTED
TSX
Comprehensive Healthcare Systems Inc. Announces Non-Brokered Private Placement and Shares for Debt Settlement
News Preview
Calgary, Alberta--(Newsfile Corp. - January 8, 2026) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (OTCQB: CMHSF) (the "Company" or "CHS"), an industry leader in healthcare benefits administration software and services, is pleased to announce a non-brokered private placement (the "Offering") of up to 7,000,000 units (the "Units") at a price o...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
1801
LISTED
HKSE
Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
News Preview
SAN FRANCISCO and SUZHOU, China, Jan. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
TLX
LISTED
NASDAQ
TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX
News Preview
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”) of the important January 9, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
So what: If...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
BKD
LISTED
NYSE
Brookdale Announces Beneficial Financing Transactions; Successfully Refinances 2026 and a Portion of 2027 Mortgage Debt
News Preview
BRENTWOOD, Tenn., Jan. 8, 2026 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or "the Company") announced today that the Company recently completed a series of financing transactions with multiple lenders totaling approximately $600 million. Through these transactions, the Company refinanced all of its approximately $350 mil...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
GOSS
LISTED
NASDAQ
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s B...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ARCT
LISTED
NASDAQ
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that Joseph Payne, President & Chief Executive Officer, will present at the 44th Annual J.P. M...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ANAB
LISTED
NASDAQ
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
News Preview
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in Delaware Chancery Court related to pending litigation between Anaptys, GSK, and TESARO, I...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
CNMD
LISTED
NYSE
CONMED Corporation Announces Chief Financial Officer Transition
News Preview
CONMED Corporation (NYSE: CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and orderly transition, Mr. Garner will remain with the Company in an advisory capacity through November 2, 2026.
CONMED has initiated a comprehensive search process, supported by a le...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
ILMN
LISTED
NASDAQ
Illumina Appoints Dr. Eric Green as Chief Medical Officer
News Preview
Veteran genomics leader joins Illumina to advance global medical strategyIllumina chief commercial officer to depart for role as a life science tools company CEO SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Today, Illumina, Inc. (NASDAQ: ILMN) announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer (CMO), effective February 2...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
PTCT
LISTED
NASDAQ
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
WARREN, N.J., Jan. 8, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 2, 2026, the company approved 300 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to a new non-executive employee. The award was made pursuant to the Nasdaq inducement gra...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
QTRX
LISTED
NASDAQ
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
News Preview
Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the “Board”) has appointed Everett Cunningham as the Company’s next President and Chief Executive Officer and a member of the Boar...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
NVST
LISTED
NYSE
Envista Schedules Fourth Quarter 2025 Earnings Call
News Preview
BREA, Calif., Jan. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2025 on Thursday, February 5, 2026. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. ...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
BMRN
LISTED
NASDAQ
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
News Preview
SAN RAFAEL, Calif., Jan. 8, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 44th Annual J.P. Morgan Conference on Monday, January 12, 2026, at 11:15 am PT / 2:15 pm ET, in San Francisco, California. The Company plans to ann...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
VEEV
LISTED
NYSE
Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
News Preview
PLEASANTON, Calif., Jan. 8, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference:
J.P. Morgan 2026 Healthcare Conference, San Francisco, CA. Brian Van Wagener, CFO, will present on Tuesday, January 13, 2026, at 1:30 p.m. Pacific Time.The above presentation will be webcast. Links to the...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
ADCT
LISTED
NYSE
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates
News Preview
Preliminary unaudited fourth quarter and full year 2025 net product revenue of approximately $22M and $73M respectively; cash and cash equivalents of approximately $261M as of December 31, 2025, provide expected cash runway at least to 2028Anticipated near-term catalysts include LOTIS-7 complete enrollment in first half of 2026 and LOTIS-5 Phase 3...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
JAZZ
LISTED
NASDAQ
Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer
News Preview
Mr. Riga brings over 25 years of commercial and operational experience with proven success leading transformative corporate development strategies and transactionsDUBLIN, Jan. 8, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Thomas Riga as Chief Business Officer, effective January 1, 2026.Mr. Riga...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
SLP
LISTED
NASDAQ
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its first quarter fiscal 2026, ended November 30, 2025.
First Quarter 2026 Financial Highlights (as compared to first quarter 20...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
SVRA
LISTED
NASDAQ
PANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*
News Preview
PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care, and Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced an exclusive distribution agreement for MOLBREEVI. Savara submitted the MOLBREEVI BLA to the...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Provides Update on Strong EKTERLY® Launch with Preliminary Fourth Quarter and Full Year 2025 Revenue Results
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today provided its preliminary fourth quarter and full year ended December 31, 2025 unaudited global net product revenue results and other operational indicators.
“We are extremely pleased with our performance since launching EKTERLY in July, which reflects steady execution, growing utilization, and...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
TNDM
LISTED
NASDAQ
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
News Preview
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2025 results after the financial markets close on Thursday, February 19, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pac...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
IMNM
LISTED
NASDAQ
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on January 2, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock o...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
VRDN
LISTED
NASDAQ
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qualifi...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
AGL
LISTED
NYSE
Securities Fraud Investigation Into agilon health, inc. (AGL) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON AGILON HEA...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
PRAX
LISTED
NASDAQ
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
News Preview
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation–inhibition imbalance, today announced the appointment of Jeffrey B. Kin...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
EBS
LISTED
NYSE
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
News Preview
GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax® (Anthrax Vaccine Adsorbed) in 2026. This order is under Emergent’s existing indefinite-delivery/indefinite-quantity (IDIQ) contrac...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
MRM
LISTED
NASDAQ
World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months
News Preview
TOKYO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM, MEDIROM or the “Company”), announces that the cumulative number of Proof of Human authentications using the World ID authentication device ‘Orb’ at stores centered on the relaxation salon “Re.Ra.Ku,” opera...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
TVRD
LISTED
NASDAQ
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Company to Highlight New Data from Phase 2 REVERT IPF Clinical Trial of TTI-101 in Podium Presentation Company to Highlight New Data from Phase 2 REVERT IPF Clinical Trial of TTI-101 in Podium Presentation...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ICCC
LISTED
NASDAQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
News Preview
PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today announced preliminary, unaudited sales results for the fourth quarter and full year of 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
TMCI
LISTED
NASDAQ
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
News Preview
PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its Lapiplasty® Lightn...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ELDN
LISTED
NASDAQ
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
News Preview
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
TLRY
LISTED
TSX
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
News Preview
International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6%...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
MMSI
LISTED
NASDAQ
Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
News Preview
SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit’s Lead Independent Director, as Chair of the Board effective January 5, 2026....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
SYRE
LISTED
NASDAQ
Spyre Therapeutics Announces Grants of Inducement Awards
News Preview
WALTHAM, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease and rheumatic diseases, today announced that Spyre’s independent Co...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
RMD
LISTED
NYSE
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
News Preview
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Oth...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
SEPN
LISTED
NASDAQ
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
News Preview
Septerna, Inc. announced the appointment of Mark A. Wilson as Chief Legal Officer....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
